| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 12/19/2001 | CN1326962A New polypeptide-human CD 63 antigen 14.63 and polynucleotide for encoding such polypeptide |
| 12/19/2001 | CN1326961A New polypeptide-humanlow density lipoprotein receptor relative protein 8.69 and polynucleotide for encoding such polypeptide |
| 12/19/2001 | CN1326960A New polypeptide-glycosyl-phosphatidyl inositol glycan F10.89 and polynucleotide for encoding such polypeptide |
| 12/19/2001 | CN1326959A New polypeptide-human TFIID subunit p 30 beta protein 12.54 and polynucleotide for encoding such polypeptide |
| 12/19/2001 | CN1326958A New polypeptide-human LAR transmembrane protein-tyrosine phosphoesterase action protein Liprins-alpha 213.97 and polynucleotide for encoding such polypeptide |
| 12/19/2001 | CN1326957A New polypeptide-human shearing factor 9.35 and polynucleotide for encoding such polypeptide |
| 12/19/2001 | CN1326956A New polypeptide-human EDF-1 protein 9.13 and polynucleotide for encoding such polypeptide |
| 12/19/2001 | CN1326955A New polypeptide-insulin-like growth factor conjugated protein 44.11 and polynucleotide for encoding such polypeptide |
| 12/19/2001 | CN1326954A New polypeptide-human mitochondrial ATP ase coupling factor F69.35 and polynucleotide for encoding such polypeptide |
| 12/19/2001 | CN1326953A New polypeptide-human 1,4,5-triphosphate inositol receptor protein 13.42 and polynucleotide for encoding such polypeptide |
| 12/19/2001 | CN1326952A New polypeptide-G-substrate protein 12.43 and polynucleotide for encoding such polypeptide |
| 12/19/2001 | CN1326951A New polypeptide-human CD63 antigen 15.07 and polynucleotide for encoding such polypeptide |
| 12/19/2001 | CN1326950A New polypeptide-human GTP conjugated protein 9.46 and polynucleotide for encoding such polypeptide |
| 12/19/2001 | CN1326949A New polypeptide-human visinin analogous protein 17.27 and polynucleotide for encoding such polypeptide |
| 12/19/2001 | CN1326943A New polypeptide-conjugated protein Ran BP236.85 and polynucleotide for encoding such polypeptide |
| 12/19/2001 | CN1326942A New polypeptide-CREB conjugated protein 30.8 and polynucleotide for encoding such polypeptide |
| 12/19/2001 | CN1326940A New polypeptide-ribosomal protein S13, 09 and polynuclotide for encoding such polypeptide |
| 12/19/2001 | CN1076356C Protein having TPO activity |
| 12/19/2001 | CN1076204C Recombinant coccidiosis vaccines |
| 12/18/2001 | US6331621 Nucleotide sequences coding protein with enzymatic activity; for use in treatment of glomeronephritis, fibrosis, cirrhosis, cancer and arthritis |
| 12/18/2001 | US6331615 Nucleic acid molecule encoding heavy or light chain of an antibody which specifically recognizes a protein specifically recognized by monoclonal antibody 5c8 (anti-CD40 ligand) |
| 12/18/2001 | US6331613 Nucleotide sequences coding protein associated with cytokine activity; for use in treating allergies, autoimmune diseases and acquired immune deficiency syndrome; for preventing cell differentiation; for activating tissue regeneration |
| 12/18/2001 | US6331612 Bone morphogenic protein-16 (BMP-16) compositions |
| 12/18/2001 | US6331433 Human T cell leukemia cell line designated D1.1 |
| 12/18/2001 | US6331423 Nucleotide sequences coding polypeptide for use as human therapeutic agents that modulate kinase activity |
| 12/18/2001 | US6331415 Methods of producing immunoglobulins, vectors and transformed host cells for use therein |
| 12/18/2001 | US6331411 TopA |
| 12/18/2001 | US6331410 Polynucleotides encoding a novel pyrR homolog |
| 12/18/2001 | US6331404 HIV envelope polypeptides |
| 12/18/2001 | US6331402 Detecting preferential particle in sample; form testing mix, incubate with sample, monitor sample for presence of preferential particle, binding indicates presence of partical |
| 12/18/2001 | US6331398 Nucleic acid ligands |
| 12/18/2001 | US6331390 Cell-cycle regulatory proteins, and uses related thereto |
| 12/18/2001 | US6331302 Protein tyrosine kinase agonist antibodies |
| 12/18/2001 | US6331301 Isolated dna sequences which encodes amino acid sequence in protein; |
| 12/18/2001 | US6331175 Method and kit for imaging and treating organs and tissues |
| 12/13/2001 | WO2001094631A1 Methods for detection of cryptosporidium species and isolates and for diagnosis of cryptosporidiuminfections |
| 12/13/2001 | WO2001094621A1 Screening method for modulators of suv39h2-methyltransferase |
| 12/13/2001 | WO2001094620A1 Screening-method for modulators of methyltransferase-dependent chromosome stability |
| 12/13/2001 | WO2001094613A2 Methods and compounds for influencing beta3 integrin-dependent intracellular processes |
| 12/13/2001 | WO2001094587A2 Extracellular messengers |
| 12/13/2001 | WO2001094586A2 Non-agonistic antibodies to human gp39, compositions containing, and therapeutic use thereof |
| 12/13/2001 | WO2001094585A1 Antibody molecules having specificity for human tumor necrosis factor alpha, and use thereof |
| 12/13/2001 | WO2001094581A1 Tumour suppressor and uses thereof |
| 12/13/2001 | WO2001094580A1 Novel g-protein coupled receptor |
| 12/13/2001 | WO2001094557A1 Human chemokine beta-10 mutant polypeptides |
| 12/13/2001 | WO2001094420A1 Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury |
| 12/13/2001 | WO2001094419A2 Method to induce the th1 immune response |
| 12/13/2001 | WO2001094418A2 Leader peptides for enhancing secretion of recombinant protein from a host cell |
| 12/13/2001 | WO2001094415A2 Nuclear hormone receptor |
| 12/13/2001 | WO2001094414A2 THE HUMAN VOLTAGE GATED SODIUM CHANNEL β-1A SUBUNIT AND METHODS OF USE |
| 12/13/2001 | WO2001094413A2 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 12/13/2001 | WO2001094400A2 A GENE ENCODING A MULTIDRUG RESISTANCE HUMAN P-GLYCOPROTEIN HOMOLOGUE ON CHROMOSOME 7p15-21 AND USES THEREOF |
| 12/13/2001 | WO2001094391A2 Intracellular signaling proteins |
| 12/13/2001 | WO2001094380A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 12/13/2001 | WO2001094377A2 Metalloprotease peptide substrates and methods |
| 12/13/2001 | WO2001094362A2 Haplotypes of the acp2 gene |
| 12/13/2001 | WO2001093983A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/13/2001 | WO2001093908A1 Immunotherapeutic method to prevent islet cell rejection |
| 12/13/2001 | WO2001093892A1 Methods and compositions for inhibiting immunoglobulin-mediated__reperfusion injury |
| 12/13/2001 | WO2001093882A1 Purified material having size and growth inhibitory effects on cells and tissues |
| 12/13/2001 | WO2001072772A3 Calcium binding regulatory subunit |
| 12/13/2001 | WO2001055325A8 Nucleic acids, proteins, and antibodies |
| 12/13/2001 | WO2001055206A8 Nucleic acids, proteins, and antibodies |
| 12/13/2001 | WO2001055205A8 Nucleic acids, proteins, and antibodies |
| 12/13/2001 | WO2001044445A3 Human lyases and associated proteins |
| 12/13/2001 | WO2001042787A3 Immunoassay for neonicotinyl insecticides |
| 12/13/2001 | WO2001040269A3 Compositions and methods for therapy and diagnosis of breast cancer |
| 12/13/2001 | WO2001036681A3 Immunological detection of rna:dna hybrids on microarrays |
| 12/13/2001 | WO2001030987A3 Tankyrase h, compositions involved in the cell cycle and methods of use |
| 12/13/2001 | WO2001026682A3 Modified plant viruses and methods of use thereof |
| 12/13/2001 | WO2001020026A3 POLYMORPHISMS IN THE HUMAN hPXR GENE AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
| 12/13/2001 | WO2001004150A3 Neisseria meningitidis compounds and anti-infection applications thereof |
| 12/13/2001 | WO2000044888A3 Dimethylarginine dimethylaminohydrolases |
| 12/13/2001 | WO2000032773A9 Compositions and methods for increasing bone mineralization |
| 12/13/2001 | WO2000015845A9 T-type calcium channel |
| 12/13/2001 | WO2000008043A9 Prevention and treatment of viral disease |
| 12/13/2001 | US20010051717 Beta (1-3) -glucan diagnostic assays |
| 12/13/2001 | US20010051710 Method of identifying cells expressing a protein having pre-B cell growth-supporting ability |
| 12/13/2001 | US20010051709 Preferential immunogenic fusion protein; for use in the treatment of autoimmune disorders |
| 12/13/2001 | US20010051708 Purifying antibody; prepare antibody suspension, mix with water soluble liquid, recover clarified antibody, apply to chromatography column, elute antibody, concentrate antibody |
| 12/13/2001 | US20010051380 Removal of abundant interfering proteins from a liquid sample using a collapsible affinity matrix |
| 12/13/2001 | US20010051372 Monoclonal immunoglublin; for use in gene therapy and cell transplantation |
| 12/13/2001 | US20010051361 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 12/13/2001 | US20010051347 Specific antibodies to kringle 5 of apo(a) and methods of use therefor |
| 12/13/2001 | US20010051159 Enhancing oral tolerance to an antigen associated with an autoimmune disease in a patient suffering from autoimmune disease comprising orally administering an antigen associated with the disease and an interleukin-12 inhibitor |
| 12/13/2001 | US20010051158 A monoclonal antibody that specifically recognizes a stimulant or hallucinogenic drug of abuse or a metabolite, selected from d-methamphetamine, d-amphetamine, 3,4-methylenedioxymethamphetamine or derivatives |
| 12/13/2001 | US20010051157 Therapeutic/cosmetic formulation for therapeutical treatment or care of sensitive human skin, hair, mucous membrane, nails and/or the scalp comprises a calcitonin gene related peptide (CGRP) antagonist and a carrier, diluent or vehicle |
| 12/13/2001 | US20010051156 Methods for inhibition of polyclonal B cell activation and immunoglobulin class switching to pathogenic autoantibodies by blocking CD1-mediated interactions |
| 12/13/2001 | US20010051155 Using immunoglobulin binding epitopes |
| 12/13/2001 | US20010051153 Grampositive bacteria; gastrointestinal disorders |
| 12/13/2001 | US20010051147 Eliminating pathogens from circulation system |
| 12/13/2001 | DE10026833A1 Verfahren zur Identifizierung von Verbindungen zur Modulierung der Aktivität eines Tumorsuppressorgens A method for identifying compounds for modulating the activity of a tumor suppressor |
| 12/13/2001 | CA2810249A1 Identification and use of human bone marrow-derived endothelial progenitor cell to improve myocardial function after ischemic injury |
| 12/13/2001 | CA2707766A1 Plasmids ptqomp and ptto-1 which have an ompa signal sequence |
| 12/13/2001 | CA2594659A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/13/2001 | CA2591930A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/13/2001 | CA2591929A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/13/2001 | CA2591814A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/13/2001 | CA2591656A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/13/2001 | CA2591590A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |